MicroCHIPS

MicroCHIPS CEO Named in Popular Science’s “Seventh Annual Brilliant 10”

BEDFORD, MA – October 14, 2008 – John Santini, Jr., PhD, CEO of MicroCHIPS, Inc., is named by Popular Science magazine as a member of the 2008 class of “young geniuses shaping the future of science.” In the history of this annual list, Dr. Santini is the only honoree who is also a successful life sciences entrepreneur running his own commercial venture. His company, MicroCHIPS, is pioneering intelligent medical devices for drug delivery and biochemical sensing.

Dr. Santini began developing the microreservoir technologies that are at the core of his company’s products as a doctoral student in the labs of Dr. Robert Langer and Dr. Michael Cima at the Massachusetts Institute of Technology. He founded MicroCHIPS with Drs. Langer and Cima as well as Terry McGuire of Polaris Venture Partners in 1999. MicroCHIPS is developing next-generation biosensing and drug delivery devices to increase therapeutic control and effectiveness for people with diabetes, osteoporosis and other debilitating diseases.

“I am honored to be a part of a list of such accomplished individuals,” said Dr. Santini, President and CEO, MicroCHIPS. “It is exciting to see our unique technologies take shape as products that can transform how clinicians and patients manage serious, chronic conditions.”

“It is gratifying to see how John is helping to move microreservoir technology from ‘bench to the bedside,’” said Robert Langer, ScD., Institute Professor at MIT. “He is working to realize our vision of innovative long-term devices that can deliver drugs and sense chemicals with exquisite control.”

Under Dr. Santini’s leadership, MicroCHIPS plans to begin clinical work in 2009 for its lead products, a long-term continuous glucose monitor for diabetes, and a drug delivery device for osteoporosis.

About MicroCHIPS

MicroCHIPS, Inc. is pioneering intelligent implanted devices designed to improve the health of millions of people with chronic conditions that require careful monitoring and precise therapy. Based on proprietary microreservoir technology first developed at MIT, MicroCHIPS’ platform incorporates long-term implant technologies and wireless communications, as well as expertise in protein and peptide formulation for challenging delivery conditions. MicroCHIPS’ technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. www.mchips.com

About Popular Science’s Annual “Brilliant 10”

For the past six years, Popular Science has published an article called "Popular Science's Brilliant 10," in which the magazine profiles ten young scientists doing work that is pushing their field to the next level. To choose the ten recipients the editors contact hundreds of individuals, including heads of departments at universities around the country, professional associations and award-granting institutions.

For more information, contact:

Maggie A. Pax, Vice President, Business Development
MicroCHIPS, Inc., mpax@mchips.com 781-522-6798 x 220